AICDA and T-cell non-Hodgkin lymphoma: AIDon mice, in contrast to our previously reported AID transgenic mice driven by the same promoter but with multiple copy integration [10], did not suffer from early death from lethal T-cell lymphoma before the age of 1 year, and survived more than 90 weeks after birth.